NCT00707590View on ClinicalTrials.gov

Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)

PHASE1TerminatedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

BMS-767778 or Placebo

Trial Locations (1)

G1P 0A2

Local Institution, Québec

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00707590 - Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter | Biotech Hunter